BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 627890)

  • 1. Cardiac chamber imaging: a comparison of red blood cells labeled with Tc-99m in vitro and in vivo.
    Hegge FN; Hamilton GW; Larson SM; Ritchie JL; Richards P
    J Nucl Med; 1978 Feb; 19(2):129-34. PubMed ID: 627890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical comparison of cardiac blood pool visualization with technetium-99m red blood cells labeled in vivo and with technetium-99m human serum albumin.
    Thrall JH; Freitas JE; Swanson D; Rogers WL; Clare JM; Brown ML; Pitt B
    J Nucl Med; 1978 Jul; 19(7):796-803. PubMed ID: 660282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acid-citrate-dextrose compared with heparin in the preparation of in vivo/in vitro technetium-99m red blood cells.
    Porter WC; Dees SM; Freitas JE; Dworkin HJ
    J Nucl Med; 1983 May; 24(5):383-7. PubMed ID: 6601697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of in vitro RBC labeling with the UltraTag RBC kit versus in vivo labeling.
    Patrick ST; Glowniak JV; Turner FE; Robbins MS; Wolfangel RG
    J Nucl Med; 1991 Feb; 32(2):242-4. PubMed ID: 1992026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of left-ventricular volume from first-pass kinetics of labeled red cells.
    Harpen MD; Dubuisson RL; Head GB; Parmley LF; Jones TB; Robinson AE
    J Nucl Med; 1983 Feb; 24(2):98-103. PubMed ID: 6296337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blood cell labeling with technetium-99m (6) radionuclide cardioangiography with technetium-99m red blood cells labeled in vivo and in vitro (author's transl)].
    Uchida T; Machii K; Ohwada K; Funayama S; Ikeda K; Ono K; Kida T; Kariyone S
    Kaku Igaku; 1979 Jun; 16(4):563-7. PubMed ID: 541888
    [No Abstract]   [Full Text] [Related]  

  • 7. Repeatability of estimates of left-ventricular volume from blood-pool counts: concise communication.
    Burns RJ; Druck MN; Woodward DS; Houle S; McLaughlin PR
    J Nucl Med; 1983 Sep; 24(9):775-81. PubMed ID: 6886811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Labeling of red blood cells with Tc-99m after oral administration of SnCl2: concise communication.
    Patel MC; Parab PB; Samuel AM; Ganatra RD
    J Nucl Med; 1979 Aug; 20(8):877-81. PubMed ID: 541736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac blood pool imaging--a clinical comparison between red blood cells labeled with 99mTc in vivo and in vitro and 99mTc-labeled human serum albumin.
    Dahlström JA; Carlsson S; Lilja B; Mattsson S; Pettersson C
    Nuklearmedizin; 1979; 18(6):271-3. PubMed ID: 537922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visualizing cardiac blood pool: comparison of three labeling methods.
    Neumann P; Schicha H; Schürnbrand P; Bähre M; Emrich D
    Eur J Nucl Med; 1983; 8(11):463-6. PubMed ID: 6653605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of modified technetium-99m albumin and technetium-99m red blood cells for equilibrium ventriculography.
    Hambÿe AS; Verbeke KA; Vandermeiren RP; Joosens EJ; Verbruggen AM; De Roo MJ
    J Nucl Med; 1997 Oct; 38(10):1521-8. PubMed ID: 9379186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of Tc-99m-labeled human serum albumin and in vitro labeled red blood cells for blood pool studies.
    Atkins HL; Klopper JF; Ansari AN; Meinken G; Richards P; Srivastava SC
    Clin Nucl Med; 1980 Apr; 5(4):166-9. PubMed ID: 7371337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radionuclide-labeled red blood cells: current status and future prospects.
    Srivastava SC; Chervu LR
    Semin Nucl Med; 1984 Apr; 14(2):68-82. PubMed ID: 6233700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of technetium-99m red blood cell labeling efficiency in adults receiving chemotherapy and the clinical impact on pediatric oncology patients.
    White MP; Mann A; Cross DM; Heller GV
    J Nucl Med Technol; 1998 Dec; 26(4):265-8. PubMed ID: 9884940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pitfall to modified in vivo method of technetium-99m red blood cell labeling. Iodinated contrast media.
    Tatum JL; Burke TS; Hirsch JI; Miller WW; Fratkin MJ
    Clin Nucl Med; 1983 Dec; 8(12):585-7. PubMed ID: 6653013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tc-99m dextran: a new blood-pool-labeling agent for radionuclide angiocardiography.
    Henze E; Robinson GD; Kuhl DE; Schelbert HR
    J Nucl Med; 1982 Apr; 23(4):348-53. PubMed ID: 6175736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radionuclide determination of right- and left-ventricular mixing.
    Harpen MD; Robinson AE
    Eur J Nucl Med; 1985; 10(1-2):5-9. PubMed ID: 2983997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on in vivo labeling rate of red blood cells eith 99mTc-pertechnetate in radionuclide angiography (author's transl)].
    Hayashida K; Nishimura T; Uehara T; Kozuka T
    Kaku Igaku; 1981 May; 18(4):495-501. PubMed ID: 6270432
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiac blood pool scanning with Tc-99m-pertechnetate-labeled albumin.
    Webber MM; Tobin PL; Bennett LR
    Radiology; 1966 Nov; 87(5):867-71. PubMed ID: 5924900
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro technetium-99m red blood cell labeling using commercial stannous pyrophosphate.
    Zimmer AM
    Am J Hosp Pharm; 1977 Mar; 34(3):264-7. PubMed ID: 857670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.